Fermentation: Aktuelle News 2025 - vegconomist: Das vegane Wirtschaftsmagazin
Fermentation | vegconomist
Seven years after our first “Top 200 Startups to Watch,” we return with the definitive 2025 list. From AI and fintech to space and defense tech, these 20 startups are shaping the future of global innovation. The tech landscape in […] The post Top Startups to Watch in 2025 first appeared on Tech Startups.| Tech Startups
Von links nach rechts: Dr. Anne Christine Steenkjaer Hastrup, (Innovation Director Biosolutions Technology Center), Johan Agrell (Vice President Sustainable Food, Abteilung Food Systems, Alfa Laval), Dr. Rohan A. Shirwaiker (Distinguished Professor Industrial & Systems Engineering und Co-Director of Bezos Center for Sustainable Protein) und Niels Peter Nørring (Director, Climate and EU Policy, Danish Agriculture & Food Council) © Alfa Laval Der internationale Technologie-Konzern Alfa Laval ...| vegconomist
Branching isn’t just for trees. This biological process occurs in animal development, enabling organs to perform complex functions. Branch-like structures form in lungs, kidneys, and breasts, among other places. Importantly, only in female mammary glands does most branching occur years after birth. It happens during puberty and again during pregnancy as milk ducts branch out... The post The magnetic math of breast health appeared first on Cold Spring Harbor Laboratory.| Cold Spring Harbor Laboratory
A central life sciences hub was designed to accelerate innovation and collaboration across New York, including Long Island| Long Island Business News
Schneider Shorts 26.09.2025 - Why papermilling is good: perspectives from university's legal counsel in Denmark, Nobel laureate and his mentee in UK, Pakistani scholars in Poland, with a cure for Huntington's and resurrected dodo, and finally, why all hope is lost for US immunology.| For Better Science
"Authors thank the members of NeuroDigitech for their contribution to data generation, and all the animals that contributed to these studies."| For Better Science
Each week we highlight five things affecting the life sciences industry. Here’s the latest. ... READ MORE >| The Real Economy Blog
SpotitEarly and the health care giant will launch the work with a 2,000-participant study focused on breast cancer. The post Hackensack Meridian, NJ startup target cancer with dog-powered diagnostic appeared first on NJBIZ.| NJBIZ
BMO analysts said in a note Monday they were “encouraged” that Genmab’s acquisition “could start to spur broader M&A in the sector.” The post Genmab Strikes $8 Billion Deal for Cancer Treatment Maker Merus appeared first on The Daily Upside.| The Daily Upside
Fermentation | vegconomist
"Cloned and genetically modified animals are entering the black market, possibly forever altering our ecosystems."| Longreads
Over the past decade, the psychedelics industry has been undergoing a second renaissance, evolving from a niche and legally questionable research area into a burgeoning field that promises to redefine mental health and wellness. As more companies, academic institutions, and non-profits explore the therapeutic potential of compounds like psilocybin, MDMA, and LSD, the role of […] The post A Trip Through the Psychedelic IP Landscape appeared first on Ocean Tomo.| Ocean Tomo
It turns out that AI really is doing the work. At least a growing chunk of it. Artificial intelligence is spreading through the global workforce like wildfire, dwarfing the adoption pace of the internet, with a new Anthropic report citing Gallup research that 40% of U.S. employees now use AI at work. While the field… The post As the pharma industry grapples with a talent shortfall, AI makes inroads in drug-safety workflows appeared first on Drug Discovery and Development.| Drug Discovery and Development
Eli Lilly launched “TuneLab,” an AI/ML platform that gives selected biotechs access to drug-discovery models trained on years of Lilly research data. Initial public partners include Circle Pharma and insitro. Lilly says the first release reflects more than $1B worth of internal data investment. Lilly says biotechs run its models locally on their own infrastructure… The post Lilly launches TuneLab, sharing AI drug-discovery models with biotechs appeared first on Drug Discovery and Develo...| Drug Discovery and Development
" I can't even begin to imagine the psychological damage of joining a lab as a new postgrad student and having people like Ryan F. Donelly as your supervisor and Andi as the postdoc, it must be heartbreaking. " - Sholto David| For Better Science
How Robin Ali and other London ophthalmologists make blind mice and blind children see.| For Better Science
“If we can target necrosis, we could unlock entirely new ways to treat conditions ranging from kidney failure to cardiac disease, neurodegeneration, and even aging itself.” – Dr Carina …| For Better Science
Scale-up ondernemers met een geweldige zorginnovatie: doe mee aan de Nationale Zorginnovatieprijs 2026! Lees er meer over en meld je aan >>| Amsterdam Economic Board
Across history, the human body has been reshaped by discipline, medicine, and now technology — each era redefining peak performance.| Freethink
The oversubscribed seed funding will be used to improve the storage and transportation of life-saving medicines, the company said.| Silicon Republic
Will Vilhelm win a Nobel Prize of his own? And for what?| For Better Science
Heart devices lead medtech’s summer financing surge. This and more in this week’s life sciences update.| The Real Economy Blog
Biotech labs are mining worm chemistry to design medicines that calm the immune system without the risks of live infection.| Freethink
From curing rare diseases to extending lifespans, four biotech founders share how AI is rewriting the future of medicine.| Freethink
Calgary, Alberta, Canada, August 11, 2025 – Marvel Biosciences Corp. (TSX-V: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the “Company” or “Marvel”), announces the award of 142,987 deferred share units (“DSUs”) to two of Marvel’s directors, in lieu of cash payment for directors’ fees.| Marvel Biosciences
By Cody Tranbarger, EIR at Atlas Venture, as part of the From The Trenches feature of LifeSciVC As the biotech industry trudges through its fourth consecutive year of middling performance and sluggish capital markets, corporate governance has become a salient The post A [Prime]r on Stock Option Repricing in Biotech appeared first on LifeSciVC.| LifeSciVC
I dati degli enti di ricerca richiedono una gestione attenta della sicurezza informatica. Scopri di più in questo articolo.| Agenda Digitale
Learn more about why this biotech company is one to watch in the green space! Eco-Cycle’s Zero Waste Hauling and Consulting Services team works with a sizable roster of local businesses to meet their recycling, composting, and hard-to-recycle hauling needs as well as guiding them toward the cutting edge of sustainable best practices. Many of […] The post Business Spotlight: SomaLogic Labs Help Pioneer New Recycling Stream appeared first on Eco-Cycle.| Eco-Cycle
And more biotech news brought to you by The Readout.| STAT
Alkermes’ investigational drug helped people with a type of narcolepsy stay awake during the day in a mid-stage trial.| STAT
In a new study, Nobel laureate David Baker and colleagues detail new methods for targeting undruggable "disordered" proteins.| STAT
Genmab, a Danish company focused on developing antibody therapies for patients with cancer, opened a new site in Plainsboro, NJ.| Drug Discovery and Development
Entdecken Sie alle Controlled Enviroment Agriculture (CEA) Nachrichten in chronologischer Reihenfolge in unserem umfangreichen Controlled Enviroment Agriculture (CEA)-News-Überblick. Bleiben Sie auf dem Laufenden über Controlled Enviroment Agriculture (CEA) und den Markt für pflanzenbasierte Produkte und zelluläre Landwirtschaft.| vegconomist
Cellugy's first lab-made ingredient is EcoFLEXY, a powder cellulose-based rheology modifier or substance that improves viscosity.| Beauty Independent
Over 200 GLP1 obesity programs are in development today. More than 300 PD1/PDL1 cancer programs exist. Greater than 150 programs target each of CD19 and KRAS. Therapeutic crowding has ratcheted up the competitive intensity in biotech to new levels. While The post Biotech Wisdom Of The Crowds: Competition And Capitalism appeared first on LifeSciVC.| LifeSciVC
You know when it’s baking and the heat is just bouncing off everything, you step in the shadows and the temperature instantly drops ten degrees? It ain’t sticking around, just bouncing right back. Anyway, I withstood this onslaught for ten minutes at London Bridge station before cramming into a train full of half-cut sweaty football fans and heading home. As the train meandred between the rooftops of Bermondsey, I caught sight of, for no more than half a second, a seagull nesting in a chi...| The Bounding Box
CellChorus®, the dynamic single-cell analysis company™, announced May 2nd that the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) has awarded CellChorus a Small Business Innovation Research (SBIR) Fast-Track grant. The funds will help advance the development of its Time-lapse Imaging Microscopy In Nanowell Grids™ (TIMING™) platform for dynamic […] The post Houston Biotech Wins $2.5 Million Award to Further Single-Cell Analysi...| Healthcare Weekly
A new bacterium identified on the Tiangong space station has surprised the scientific community with its ability to withstand extreme conditions beyond Earth.| Techoreon
The post Marvel Biosciences to Give Oral Presentation at the Annual IRSF Rett Syndrome Scientific Meeting appeared first on Marvel Biosciences.| Marvel Biosciences
In new research, Xuelin Li, Sijie Wang, Jiajie Xu, and Xiang Zheng find that the involvement of specialized venture capital firms influences a biotech startup’s drug portfolio by focusing research and development on fewer products.| ProMarket
The equity markets have collapsed in 2025, the IPO window is closed, the FDA is in turmoil, the NIH is being gutted… and it’s a great time to start new biotech companies. Why? Because there are so few being created The post Biotech Venture Creation: The Benefits Of Scarcity appeared first on LifeSciVC.| LifeSciVC
The post Marvel Biosciences to File for Orphan Drug Designation with the U.S. FDA for MB-204 as a Treatment for Rett Syndrome appeared first on Marvel Biosciences.| Marvel Biosciences
Cambridge-based TRIMTECH Therapeutics, a BioTech company harnessing targeted protein degradation (TPD) for the treatment of neurodegenerative diseases,| EU-Startups
Medical Communications (MedComms) might just be the best industry career option out there for scientists who most enjoy the writing/communicating/organising parts of the job, and on 22nd November 2…| Total Internal Reflection
“No paper — I would wager quite heavily that a large percentage, probably over 90% of papers in the public domain, have errors in them. Whether or not they be known, I would suggest th…| For Better Science
There are a number of innovative applications that dry ice is being used for in the medical industry—it doesn't stop at basic refrigeration!| Dry Ice Corp
“your scatter gun approach has undermind a process that is undertaken confidentially […] It is sad that you are determined to undermine people’s reputations in the way you do.…| For Better Science
I've been listening to Hidden Forces with Demetri Kofinas for years now. He's an excellent interviewer with interests in finance, geopolit...| infoproc.blogspot.com
